_id
6915f56dbc934aba376b2353
Ticker
SCYRD
Name
SCYRD
Exchange
PINK
Address
65 International Boulevard, Toronto, ON, Canada, M9W 6L9
Country
USA
Sector
Technology
Industry
Software - Infrastructure
Currency
USD
Website
https://www.scryb.ai
Description
Scryb Inc., a technology company, holds ownership in various businesses and technologies from the fields of digital health, cybersecurity, biotech, and artificial intelligence. The company offers Cybeats, a supply chain cybersecurity; Fionet platform, a mobile IT/Data platform for decentralized healthcare testing and patient management; and Raidian, an AI government platform, to enhance AI safety and trustworthiness for enterprises that are managing multiple AI systems and provide management tools for compliance with impending AI regulation. It also provides nutraceutical and cannabinoid-based products. The company was formerly known as Relay Medical Corp. and changed its name to Scryb Inc. in December 2021. Scryb Inc. is headquartered in Toronto, Canada.
Last Close
0.073
Volume
-
Current Price
0.073
Last Updated
2025-11-23T19:08:55.108Z
Image
data:image/webp;base64,UklGRswBAABXRUJQVlA4IMABAADwCwCdASo/AEAAPq1GnEmmI6KhMBn9+MAViWwAxcYgi4ws+ABtgPMB50Hpa3pnehQmQRfiiQfcl+0eb2gh+B9YjuP0SM4vm9FQlYRk2AOl8XUxCoS/iCncN1+G/x/iAYKK+aRx4/0ZKAD++yGCf9EI0pb+1pPrL55jRAratj2AseVvutPad+KaGAjDdHt8F1ItCBu/aIcrAeSoTdnPbaws18AQc+siy8ZeFu60L2LAMNFq6hw5T7c4eamktxCludFxOdtcHuJ8t5gbt1rp6Cf4IvVGNCFJqG8zM3tFG33ksrgzFKfAcBRWvYtnWx6eflI9/JB6yYNFjuyr6VaCF3gpyb3scfuFfVezLZdfPtRaxCFCiVEKGGyj5UTwrtysJyKLkMsnRmwUm5ZYXGmGkK6WtoANBhXXoCK3a5eHRWVXVlRJFp2g0/F8dtAGNasb0pUG/hmkXcUyO4qyR6hMdanmPAozkQPZRvk/u/D8pHakY8Pz9R7xN/2kwxr0QJoBB7OJByJO9BIjBjcKEMizKxPA4ogDMsCPkMmuRHGB4aed+ETfldzUkEz9+nmNBnp6i76JvsvJPXXgMV+MxcVGYoAA
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
107683
Cost Of Revenue
-100000
Gross Profit
107683
Operating Expenses
487341
Operating Income
-379658
Interest Expense
66236
Pretax Income
-1237620
Net Income
-1237620
Eps
-0.03829418263028576
Dividends Per Share
-
Shares Outstanding
32318747
Income Tax Expense
-
EBITDA
-
Operating Margin
-352.57004355376426
Total Other Income Expense Net
-791723
Cash
64015
Short Term Investments
522268
Receivables
3560
Inventories
-
Total Current Assets
804479
Property Plant Equipment
128538
Total Assets
11701916
Payables
1055488
Short Term Debt
-
Long Term Debt
1189767
Total Liabilities
2878577
Equity
8823339
Depreciation
24086
Change In Working Capital
130018
Cash From Operations
-668830
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-680088
Net Change In Cash
-146462
PE
-
PB
0.26738953711287755
ROE
-14.026662695380967
ROA
-10.576216749462224
FCF
-668830
Fcf Percent
-6.211101102309557
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
107683
Quarters > 0 > income Statement > cost Of Revenue
-100000
Quarters > 0 > income Statement > gross Profit
107683
Quarters > 0 > income Statement > operating Expenses
487341
Quarters > 0 > income Statement > operating Income
-379658
Quarters > 0 > income Statement > interest Expense
66236
Quarters > 0 > income Statement > pretax Income
-1237620
Quarters > 0 > income Statement > net Income
-1237620
Quarters > 0 > income Statement > eps
-0.03829418263028576
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
32318747
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-352.57004355376426
Quarters > 0 > income Statement > total Other Income Expense Net
-791723
Quarters > 0 > balance Sheet > cash
64015
Quarters > 0 > balance Sheet > short Term Investments
522268
Quarters > 0 > balance Sheet > receivables
3560
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
804479
Quarters > 0 > balance Sheet > property Plant Equipment
128538
Quarters > 0 > balance Sheet > total Assets
11701916
Quarters > 0 > balance Sheet > payables
1055488
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
1189767
Quarters > 0 > balance Sheet > total Liabilities
2878577
Quarters > 0 > balance Sheet > equity
8823339
Quarters > 0 > cash Flow > net Income
-1237620
Quarters > 0 > cash Flow > depreciation
24086
Quarters > 0 > cash Flow > change In Working Capital
130018
Quarters > 0 > cash Flow > cash From Operations
-668830
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-680088
Quarters > 0 > cash Flow > net Change In Cash
-146462
Quarters > 0 > ratios > PE
-0.03829418263028576
Quarters > 0 > ratios > PB
0.26738953711287755
Quarters > 0 > ratios > ROE
-14.026662695380967
Quarters > 0 > ratios > ROA
-10.576216749462224
Quarters > 0 > ratios > FCF
-668830
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-6.211101102309557
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
13700
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
782803
Quarters > 1 > income Statement > operating Income
-769103
Quarters > 1 > income Statement > interest Expense
128704
Quarters > 1 > income Statement > pretax Income
-1159629
Quarters > 1 > income Statement > net Income
-781661
Quarters > 1 > income Statement > eps
-0.024185993349308994
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
32318747
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-5613.890510948905
Quarters > 1 > income Statement > total Other Income Expense Net
-261822
Quarters > 1 > balance Sheet > cash
210478
Quarters > 1 > balance Sheet > short Term Investments
1056923
Quarters > 1 > balance Sheet > receivables
0
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3293340
Quarters > 1 > balance Sheet > property Plant Equipment
152624
Quarters > 1 > balance Sheet > total Assets
13680237
Quarters > 1 > balance Sheet > payables
948615
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
1189033
Quarters > 1 > balance Sheet > total Liabilities
3448506
Quarters > 1 > balance Sheet > equity
10231731
Quarters > 1 > cash Flow > net Income
-781661
Quarters > 1 > cash Flow > depreciation
23020
Quarters > 1 > cash Flow > change In Working Capital
-672889
Quarters > 1 > cash Flow > cash From Operations
-1273908
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1655139
Quarters > 1 > cash Flow > net Change In Cash
-226191
Quarters > 1 > ratios > PE
-0.024185993349308994
Quarters > 1 > ratios > PB
0.23058351817497938
Quarters > 1 > ratios > ROE
-7.639577311014138
Quarters > 1 > ratios > ROA
-5.713797209799801
Quarters > 1 > ratios > FCF
-1273908
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-92.98598540145986
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
224903
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1715813
Quarters > 2 > income Statement > operating Income
-1490910
Quarters > 2 > income Statement > interest Expense
158843
Quarters > 2 > income Statement > pretax Income
8175645
Quarters > 2 > income Statement > net Income
8553612
Quarters > 2 > income Statement > eps
0.2665893561942777
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32085347
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-662.9124555919664
Quarters > 2 > income Statement > total Other Income Expense Net
9825395
Quarters > 2 > balance Sheet > cash
436668
Quarters > 2 > balance Sheet > short Term Investments
667494
Quarters > 2 > balance Sheet > receivables
1687287
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2982728
Quarters > 2 > balance Sheet > property Plant Equipment
174575
Quarters > 2 > balance Sheet > total Assets
13528196
Quarters > 2 > balance Sheet > payables
1319179
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
135641
Quarters > 2 > balance Sheet > total Liabilities
2382276
Quarters > 2 > balance Sheet > equity
11145920
Quarters > 2 > cash Flow > net Income
8553612
Quarters > 2 > cash Flow > depreciation
280274
Quarters > 2 > cash Flow > change In Working Capital
618469
Quarters > 2 > cash Flow > cash From Operations
-916812
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-131635
Quarters > 2 > cash Flow > net Change In Cash
277683
Quarters > 2 > ratios > PE
0.2665893561942777
Quarters > 2 > ratios > PB
0.21014239569277365
Quarters > 2 > ratios > ROE
76.74209037925985
Quarters > 2 > ratios > ROA
63.228031291090105
Quarters > 2 > ratios > FCF
-916812
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-4.076477414707674
Quarters > 2 > health Score
73
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
1673472
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
11961885
Quarters > 3 > income Statement > operating Income
-10288413
Quarters > 3 > income Statement > interest Expense
467907
Quarters > 3 > income Statement > pretax Income
-10984343
Quarters > 3 > income Statement > net Income
-6776388
Quarters > 3 > income Statement > eps
-0.232739623681989
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
29115747
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-614.7944512964663
Quarters > 3 > income Statement > total Other Income Expense Net
-228023
Quarters > 3 > balance Sheet > cash
158986
Quarters > 3 > balance Sheet > short Term Investments
247500
Quarters > 3 > balance Sheet > receivables
854812
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2438812
Quarters > 3 > balance Sheet > property Plant Equipment
32940
Quarters > 3 > balance Sheet > total Assets
8804673
Quarters > 3 > balance Sheet > payables
4627568
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
2111135
Quarters > 3 > balance Sheet > total Liabilities
10508280
Quarters > 3 > balance Sheet > equity
1042499
Quarters > 3 > cash Flow > net Income
-6776388
Quarters > 3 > cash Flow > depreciation
790580
Quarters > 3 > cash Flow > change In Working Capital
4659289
Quarters > 3 > cash Flow > cash From Operations
-8352311
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
4692942
Quarters > 3 > cash Flow > net Change In Cash
262124
Quarters > 3 > ratios > PE
-0.232739623681989
Quarters > 3 > ratios > PB
2.0388024650383354
Quarters > 3 > ratios > ROE
-650.0138609245669
Quarters > 3 > ratios > ROA
-76.9635397021559
Quarters > 3 > ratios > FCF
-8352311
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-4.991007318915405
Quarters > 3 > health Score
16
Valuation > metrics > PE
-0.03829418263028576
Valuation > metrics > PB
0.26738953711287755
Valuation > final Score
70
Valuation > verdict
73.3% Undervalued
Profitability > metrics > ROE
-14.026662695380967
Profitability > metrics > ROA
-153.84118168404643
Profitability > metrics > Net Margin
-11.493179053332467
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3262457670503196
Risk > metrics > Interest Coverage
-5.731898061477143
Risk > final Score
37
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.762186779953917
Liquidity > metrics > Quick Ratio
0.762186779953917
Liquidity > final Score
48
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
90
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
100
Prev Profitabilities > 2
0
Prev Risks > 0
36
Prev Risks > 1
22
Prev Risks > 2
-82
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
36
Updated At
2026-01-20T22:32:27.968Z
Scryb Inc., a technology company, holds ownership in various businesses and technologies from the fields of digital health, cybersecurity, biotech, and artificial intelligence. The company offers Cybeats, a supply chain cybersecurity; Fionet platform, a mobile IT/Data platform for decentralized healthcare testing and patient management; and Raidian, an AI government platform, to enhance AI safety and trustworthiness for enterprises that are managing multiple AI systems and provide management tools for compliance with impending AI regulation. It also provides nutraceutical and cannabinoid-based products. The company was formerly known as Relay Medical Corp. and changed its name to Scryb Inc. in December 2021. Scryb Inc. is headquartered in Toronto, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHome Stocks Go Ape Over Google. Why Zillow, and Others Arenât Scared. Barron's
Read more ââWeâre not scaredâ: Life in Taiwan goes on amid major Chinese war games Al Jazeera
Read more âShowing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ⤠1
High ⼠3
Return on Equity (ROE)
-
Very Low
Low ⤠5%
High ⼠25%
Return on Assets (ROA)
-
Very Low
Low ⤠2%
High ⼠10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ⤠5%
High ⼠15%
Debt to Equity
-
Very High
Low ⼠1
High ⤠0.3
* Institutions hold a combined 0.00% of the total shares of SCYRD
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.